Authors: Bluemke, DA Stillman, AE Bis, KG Grist, TM Baum, RA D'Agostino, R Malden, ES Pierro, JA Yucel, EK

Citation: Da. Bluemke et al., Carotid MR angiography: Phase II study of safety and efficacy for MS-325, RADIOLOGY, 219(1), 2001, pp. 114-122

Authors: Rubin, DL Desser, TS Semelka, R Brown, J Nghiem, HV Stevens, WR Bluemke, D Nelson, R Fultz, P Reimer, P Ho, V Kristy, RM Pierro, JA

Citation: Dl. Rubin et al., A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial, J MAGN R I, 9(2), 1999, pp. 240-250

Authors: Swan, SK Baker, JF Free, R Tucker, RM Barron, B Barr, R Seltzer, S Gazelle, GS Maravilla, KR Barr, W Stevens, GR Lambrecht, LJ Pierro, JA

Citation: Sk. Swan et al., Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function, J MAGN R I, 9(2), 1999, pp. 317-321